ON-X LIFE TECHNOLOGIES INC.

ON-X LIFE TECHNOLOGIES INC. specializes in the design, development, and manufacturing of advanced medical devices, with a technical focus on cardiovascular and life-support systems. Leveraging precision engineering and biocompatible materials, the company delivers critical components used in extracorporeal circulation, blood oxygenation, and cardiac assist technologies. Their expertise includes fluid dynamics modeling, sterile packaging validation, and regulatory-compliant manufacturing processes aligned with FDA 21 CFR Part 820 and ISO 13485 standards. Differentiators include proprietary membrane technologies and integrated sensor systems designed for high-reliability clinical environments, emphasizing durability, hemocompatibility, and minimal thrombogenicity in patient-critical applications. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal contract performance can be inferred. Without recent contract data, it is not possible to identify which government entities rely on their products or the nature of any public-sector procurement relationships. The company operates primarily under NAICS 334510, which encompasses the manufacturing of surgical and medical instruments and devices. In practice, this translates to the development of Class II and Class III medical devices intended for use in hospital ICUs, cardiac surgery suites, and emergency transport systems. Their market positioning centers on high-complexity, low-volume medical hardware requiring stringent quality control and regulatory oversight, serving both commercial healthcare providers and potential government medical supply chains. ON-X LIFE TECHNOLOGIES INC. is structured as a 2L entity based in Austin, Texas, with no disclosed government certifications such as 8(a), HUBZone, or SDVOSB. The company’s geographic footprint is limited to its primary manufacturing and R&D facility in Texas, with no public indication of federal contracting offices or multi-state operational presence. Their business model reflects a niche, engineering-driven approach to medical device production rather than broad-based government services.